CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory-Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand.
Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory-Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
具有干细胞记忆(TSCM)表型的 T 细胞可为 T 细胞过继转移疗法提供持久且强效的抗肿瘤作用。尽管已有多种体外诱导 TSCM 样细胞的方法,但鲜有方法能从效应/耗竭 T 细胞生成 TSCM 样细胞。我们此前报道,与表达 Notch 配体的 OP9 基质细胞共培养可诱导 TSCM 样(iTSCM)细胞。本研究建立一种无饲养层培养系统,以改善扩增后的嵌合抗原受体(CAR)表达 T 细胞生成 iTSCM 细胞的效率:在 IL7、CXCL12、IGF-I 和 Notch 配体 hDLL1 存在下培养 CAR-T 细胞。无饲养层 CAR-iTSCM 细胞表达的细胞表面标志物和基因与 OP9-hDLL1 饲养层诱导的 CAR-iTSCM 细胞相似,包括干细胞记忆相关基因 TCF7、LEF1 和 BCL6 表达升高,以及耗竭相关基因 LAG3、TOX 和 NR4A1 表达降低。无饲养层 CAR-iTSCM 细胞具有更强增殖能力,依赖氧化磷酸化;与饲养层诱导的细胞相比,其 IL2 生成更多,体内抗肿瘤活性更强。该无饲养层培养系统可使效应/耗竭 CAR-T 细胞重焕活力,转变为干细胞记忆样 CAR-T 细胞。 意义:使用本研究定义的因子使静息 CAR-T 细胞重新编程,令其从耗竭状态转变为干细胞记忆样状态,从而有助于开发疗效更佳的 CAR-T 细胞疗法。
UNLABELLED: T cells with a stem cell memory (T SCM ) phenotype provide long-term and potent antitumor effects for T-cell transfer therapies. Although various methods for the induction of T SCM -like cells in vitro have been reported, few methods generate T SCM -like cells from effector/exhausted T cells.
We have reported that coculture with the Notch ligand-expressing OP9 stromal cells induces T SCM -like (iT SCM ) cells.
Here, we established a feeder-free culture system to improve iT SCM cell generation from expanded chimeric antigen receptor (CAR)-expressing T cells; culturing CAR T cells in the presence of IL7, CXCL12, IGF-I, and the Notch ligand, hDLL1.
Feeder-free CAR-iT SCM cells showed the expression of cell surface markers and genes similar to that of OP9-hDLL1 feeder cell-induced CAR-iT SCM cells, including the elevated expression of SCM-associated genes, TCF7 , LEF1 , and BCL6 , and reduced expression of exhaustion-associated genes like LAG3 , TOX , and NR4A1 . Feeder-free CAR-iT SCM cells showed higher proliferative capacity depending on oxidative phosphorylation and exhibited higher IL2 production and stronger antitumor activity in vivo than feeder cell-induced CAR-iT SCM cells.
Our feeder-free culture system represents a way to rejuvenate effector/exhausted CAR T cells to SCM-like CAR T cells. SIGNIFICANCE: Resting CAR T cells with our defined factors reprograms exhausted state to SCM-like state and enables development of improved CAR T-cell therapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。